# OnCo record mays-cancer-center (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/mays-cancer-center/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "mays-cancer-center" ;
  schema:name "Mays Cancer Center at UT Health San Antonio"@en ;
  schema:alternateName "CTRC"@en, "Cancer Therapy & Research Center"@en ;
  schema:description "Mays Cancer Center in San Antonio, NCI-designated since 1991, hosts the San Antonio Breast Cancer Symposium and descends from the CTRC phase 1 institute where Daniel Von Hoff ran early trials of gemcitabine and nab-paclitaxel; it serves South Texas's predominantly Latino population."@en ;
  schema:url <https://onco.cc/institutions/mays-cancer-center/>, <https://cancer.uthscsa.edu> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://cancer.uthscsa.edu>, <https://www.sabcs.org> ;
  schema:addressCountry "US" ;
  schema:addressLocality "San Antonio, TX" ;
  schema:latitude "29.508"^^xsd:decimal ;
  schema:longitude "-98.575"^^xsd:decimal ;
  onco:related <https://onco.cc/collections/src-sabcs/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/ruxolitinib/> ;
  onco:institutions <https://onco.cc/institutions/aacr/>, <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/nct01906385/> ;
  onco:people <https://onco.cc/people/lei-zheng/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-diversity/> .
